Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 7, 2011, Pages 401-404

  Magand, Florence ^a   Nacher, Mathieu ^a   Cazorla, Céline ^b   Cambazard, Frederic ^b   Marie, Dominique Sainte ^a   Couppié, Pierre ^a  

^a CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

HAART; Herpes zoster; HIV; Prurigo nodularis; Tropical areas; WHO classification

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; FRENCH GUIANA; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; PRURIGO; PRURIGO NODULARIS; RETROSPECTIVE STUDY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; FRENCH GUIANA; HERPES ZOSTER; HIV SEROPOSITIVITY; HUMANS; IMMUNE TOLERANCE; MALE; PREDICTIVE VALUE OF TESTS; PRURIGO; RETROSPECTIVE STUDIES;

HERPES ZOSTER;

EID: 80955180599     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.04.001     Document Type: Article

References (18)

1. Nacher M., Huber F., El Guedj M., Vaz T., Magnien C., Djossou F., et al. Risk factors for death among patients in French Guiana: 1996-2005. HIV Med 2007, 8:472-474.
2. Dover J.S., Johnson R.A. Cutaneous manifestations of human immunodeficiency virus infection. Part I. Arch Dermatol 1991, 127:1383-1391.
3. Coldiron B.M., Bergstresser P.R. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989, 125:357-361.
4. Coopman S.A., Johnson R.A., Platt R., Stern R.S. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993, 328:1670-1674.
5. WHO. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization; 2007.
6. Muhammad B., Eligius L., Mugusi F., Aris E., Chale S., Magao P., et al. The prevalence and pattern of skin diseases in relation to CD4 counts among HIV-infected police officers in Dar es Salaam. Trop Doct 2003, 33:44-48.
7. Goldstein B., Berman B., Sukenik E., Frankel S.J. Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS. J Am Acad Dermatol 1997, 36:262-264.
8. Monsel G., Ly F., Canestri A., Diousse P., Ndiaye B., Caumes E. Prevalence of skin disorders in HIV patients in Senegal and relationship to degree of immunosuppression [in French]. Ann Dermatol Venereol 2008, 135:187-193.
9. Tyndall M.W., Nasio J., Agoki E., Malisa W., Ronald A.R., Ndinya-Achola J.O., et al. Herpes zoster as the initial presentation of human immunodeficiency virus type 1 infection in Kenya. Clin Infect Dis 1995, 21:1035-1037.
10. Goodman D.S., Teplitz E.D., Wishner A., Klein R.S., Burk P.G., Hershenbaum E. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 1987, 17:210-220.
11. Mahe A., Bobin P., Coulibaly S., Tounkara A. Skin diseases disclosing human immunodeficiency virus infection in Mali [in French]. Ann Dermatol Venereol 1997, 124:144-150.
12. Colebunders R., Mann J., Francis H., Bila K., Izaley L., Kakonde N., et al. Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection. AIDS 1987, 1:117-121.
13. Liautaud B., Pape J.W., DeHowitz J.A., Thomas F., Laroche A.C., Verdier R.I., et al. Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 1989, 125:629-632.
14. Gonzaga H.F., Jorge M.A., Gonzaga L.H., Barbosa C.A., Chaves M.D. Systemic and oral alterations in Brazilian patients with cutaneous herpes zoster. Braz Dent J 2002, 13:49-52.
15. Edhonu-Eletu Y. Significance of herpes zoster in HIV/AIDS in Kweneng district, Botswana. East Afr Med J 1998, 75:379-381.
16. Dehne K.L., Dhlakama D.G., Richter C., Mawadza M., McClean D., Huss R. Herpes zoster as an indicator of HIV infection in Africa. Trop Doct 1992, 22:68-70.
17. Colebunders R., Mann J.M., Francis H., Bila K., Izaley L., Kakonde N., et al. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J Infect Dis 1988, 157:314-318.
18. Lesbordes J.L., Coulaud X. Zona in human immunodeficiency virus (HIV-1) infection in Bangui (Central Africa) [in French]. Med Trop (Mars) 1988, 48:409-411.